UPDATE 1-Evofem non-hormonal birth control gel gets FDA approval, to be priced at up to $275

The U.S. Food and Drug Administration on Friday approved Evofem Biosciences Inc's birth control gel, ushering in the first non-hormonal contraceptive for women in over three decades, sending its shares up 3.6%.